(Q34741560)

4 August 2017

1 reference

title

Emerging immune targets for the therapy of allergic asthma (English)

1 reference

4 August 2017

0 references

1 reference

David B Corry

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

Nature Reviews Drug Discovery

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

55-64

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd702

4 August 2017

exact match

0 references

cites work

Epidemiology of asthma: the year in review

1 reference

The epidemic of allergy and asthma

31 March 2020

1 reference

Global initiative for asthma (GINA) and its objectives

31 March 2020

1 reference

Immunologic basis of antigen-induced airway hyperresponsiveness

31 March 2020

1 reference

Interleukin-13: central mediator of allergic asthma

31 March 2020

1 reference

Requirement for IL-13 independently of IL-4 in experimental asthma

31 March 2020

1 reference

Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15.

31 March 2020

1 reference

IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells

31 March 2020

1 reference

Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor

31 March 2020

1 reference

Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells

31 March 2020

1 reference

An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits responses to IL-4.

31 March 2020

1 reference

IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain

31 March 2020

1 reference

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

31 March 2020

1 reference

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

31 March 2020

1 reference

Functional diversity of helper T lymphocytes

31 March 2020

1 reference

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

31 March 2020

1 reference

T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family

31 March 2020

1 reference

Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking

31 March 2020

1 reference

Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation

31 March 2020

1 reference

Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.

31 March 2020

1 reference

The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function

31 March 2020

1 reference

T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses

31 March 2020

1 reference

CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4.

31 March 2020

1 reference

The roles of CD28 and CD40 ligand in T cell activation and tolerance

31 March 2020

1 reference

CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma

31 March 2020

1 reference

Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma

31 March 2020

1 reference

Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model

31 March 2020

1 reference

Lymphocyte homing and homeostasis

31 March 2020

1 reference

The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics

31 March 2020

1 reference

CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease

31 March 2020

1 reference

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

31 March 2020

1 reference

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

31 March 2020

1 reference

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

31 March 2020

1 reference

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

31 March 2020

1 reference

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c

31 March 2020

1 reference

CC chemokine receptor-2 is not essential for the development of antigen-induced pulmonary eosinophilia and airway hyperresponsiveness

31 March 2020

1 reference

Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells

31 March 2020

1 reference

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

31 March 2020

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

31 March 2020

1 reference

Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma

31 March 2020

1 reference

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

31 March 2020

1 reference

Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

31 March 2020

1 reference

Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity

31 March 2020

1 reference

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

31 March 2020

1 reference

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

31 March 2020

1 reference

IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development

31 March 2020

1 reference

Heteromerization of the c Chain with the Interleukin-9 Receptor Subunit Leads to STAT Activation and Prevention of Apoptosis

31 March 2020

1 reference

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

31 March 2020

1 reference

T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6.

31 March 2020

1 reference

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation

31 March 2020

1 reference

The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells

31 March 2020

1 reference

Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

31 March 2020

1 reference

Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3

31 March 2020

1 reference

A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation

31 March 2020

1 reference

Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis

31 March 2020

1 reference

Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID

31 March 2020

1 reference

Peripheral expression of Jak3 is required to maintain T lymphocyte function

31 March 2020

1 reference

Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

31 March 2020

1 reference

Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha

31 March 2020

1 reference

Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice

31 March 2020

1 reference

Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice

31 March 2020

1 reference

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

31 March 2020

1 reference

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

31 March 2020

1 reference

Impaired Th2 subset development in the absence of CD4.

31 March 2020

1 reference

Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice

31 March 2020

1 reference

CD4 dependence of activation threshold and TCR signalling in mouse T lymphocytes

31 March 2020

1 reference

A Toll-like receptor recognizes bacterial DNA

31 March 2020

1 reference

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

31 March 2020

1 reference

Differential effects of endogenous and exogenous interferon-gamma on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma

31 March 2020

1 reference

Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

31 March 2020

1 reference

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

31 March 2020

1 reference

Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells

31 March 2020

1 reference

Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism

31 March 2020

1 reference

CpG DNA: security code for host defense

31 March 2020

1 reference

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

31 March 2020

1 reference

Antisense strategies: functions and applications in immunology.

31 March 2020

1 reference

Peptide nucleic acids: on the road to new gene therapeutic drugs.

31 March 2020

1 reference

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

31 March 2020

1 reference

Virus treatment questioned after gene therapy death

31 March 2020

1 reference

Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD702

1 reference

4 August 2017

1 reference